chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Escherichia test positive, Hyporesponsive to stimuli, Infectious pleural effusion, Laboratory test abnormal, Leukocytosis
Clinical narrative: Admit date: 12/31/2023  Discharge date: 1/5/2024   Admitting Physician: DO   Attending Physician at the Time of Discharge: DO  Primary Care Physician: MD  Hospital Course: 81 YO female with medical history notable for   Advanced Alzheimer,  recent COVID infection, poor oral intake, failure to thrive, impaired mobility, hypothyroidism, normocytic anemia who presented to Hospital for   Increasing shortness of breath and cough as well as decreased responsiveness.  Patient had COVID-19 infection roughly around November, patient's symptoms initially improving, however gradually worsening before admission.  Patient was nonsmoker largely bed-bound. Per son, patient has a small decubitus rash and now enlarging.  Patient is nonverbal at baseline, able to respond to pain.  On admission, patient afebrile, hemodynamically stable, in room air.  Lab shows leukocytosis with neutrophil predominant. CT pulmonary, results shows  Pulmonary emboli in the segmental branches to the right upper lobe. Borderline right heart strain. Heterogenous consolidation in the left lower lobe with multiple low-attenuation areas suspicious for underlying infiltrative mass or areas of liquefaction. Moderate partially loculated left pleural effusion insinuating in the left fissure. Mild mediastinal lymphadenopathy. RVP return COVID positive, patient was blood culture later returns Staphylococcus hominis/ epidermidis 2/2.  Patient also found urine culture shows E coli and Enterococcus faecalis. Patient was placed on Unasyn and vancomycin since then  Concerning necrotizing pneumonia  with a parapneumonic effusion, urinary tract infection, decubitus ulcer.  Patient underwent thoracentesis, results shows neutrophil predominant LDH elevated exudate. Patient was later placed only on Unasyn as the blood infection seemed to be just a contaminant. Patient continued to be stable and after being seen by pulmonology, the plan was to continue antibiotic course for 4 weeks of antibiotics, and to have a repeat chest CT in 6 weeks from discharge. This plan was discussed with the patient's son and he expressed understanding. Patient was discharged in stable condition.  Discharged to Home
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Lung consolidation, Neutrophil count, Pleural effusion, Pneumonia necrotising, Pulmonary embolism
Clinical narrative: Admit date: 12/31/2023  Discharge date: 1/5/2024   Admitting Physician: DO   Attending Physician at the Time of Discharge: DO  Primary Care Physician: MD  Hospital Course: 81 YO female with medical history notable for   Advanced Alzheimer,  recent COVID infection, poor oral intake, failure to thrive, impaired mobility, hypothyroidism, normocytic anemia who presented to Hospital for   Increasing shortness of breath and cough as well as decreased responsiveness.  Patient had COVID-19 infection roughly around November, patient's symptoms initially improving, however gradually worsening before admission.  Patient was nonsmoker largely bed-bound. Per son, patient has a small decubitus rash and now enlarging.  Patient is nonverbal at baseline, able to respond to pain.  On admission, patient afebrile, hemodynamically stable, in room air.  Lab shows leukocytosis with neutrophil predominant. CT pulmonary, results shows  Pulmonary emboli in the segmental branches to the right upper lobe. Borderline right heart strain. Heterogenous consolidation in the left lower lobe with multiple low-attenuation areas suspicious for underlying infiltrative mass or areas of liquefaction. Moderate partially loculated left pleural effusion insinuating in the left fissure. Mild mediastinal lymphadenopathy. RVP return COVID positive, patient was blood culture later returns Staphylococcus hominis/ epidermidis 2/2.  Patient also found urine culture shows E coli and Enterococcus faecalis. Patient was placed on Unasyn and vancomycin since then  Concerning necrotizing pneumonia  with a parapneumonic effusion, urinary tract infection, decubitus ulcer.  Patient underwent thoracentesis, results shows neutrophil predominant LDH elevated exudate. Patient was later placed only on Unasyn as the blood infection seemed to be just a contaminant. Patient continued to be stable and after being seen by pulmonology, the plan was to continue antibiotic course for 4 weeks of antibiotics, and to have a repeat chest CT in 6 weeks from discharge. This plan was discussed with the patient's son and he expressed understanding. Patient was discharged in stable condition.  Discharged to Home
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, SARS-CoV-2 test positive, Staphylococcus test positive, Urinary tract infection
Clinical narrative: Admit date: 12/31/2023  Discharge date: 1/5/2024   Admitting Physician: DO   Attending Physician at the Time of Discharge: DO  Primary Care Physician: MD  Hospital Course: 81 YO female with medical history notable for   Advanced Alzheimer,  recent COVID infection, poor oral intake, failure to thrive, impaired mobility, hypothyroidism, normocytic anemia who presented to Hospital for   Increasing shortness of breath and cough as well as decreased responsiveness.  Patient had COVID-19 infection roughly around November, patient's symptoms initially improving, however gradually worsening before admission.  Patient was nonsmoker largely bed-bound. Per son, patient has a small decubitus rash and now enlarging.  Patient is nonverbal at baseline, able to respond to pain.  On admission, patient afebrile, hemodynamically stable, in room air.  Lab shows leukocytosis with neutrophil predominant. CT pulmonary, results shows  Pulmonary emboli in the segmental branches to the right upper lobe. Borderline right heart strain. Heterogenous consolidation in the left lower lobe with multiple low-attenuation areas suspicious for underlying infiltrative mass or areas of liquefaction. Moderate partially loculated left pleural effusion insinuating in the left fissure. Mild mediastinal lymphadenopathy. RVP return COVID positive, patient was blood culture later returns Staphylococcus hominis/ epidermidis 2/2.  Patient also found urine culture shows E coli and Enterococcus faecalis. Patient was placed on Unasyn and vancomycin since then  Concerning necrotizing pneumonia  with a parapneumonic effusion, urinary tract infection, decubitus ulcer.  Patient underwent thoracentesis, results shows neutrophil predominant LDH elevated exudate. Patient was later placed only on Unasyn as the blood infection seemed to be just a contaminant. Patient continued to be stable and after being seen by pulmonology, the plan was to continue antibiotic course for 4 weeks of antibiotics, and to have a repeat chest CT in 6 weeks from discharge. This plan was discussed with the patient's son and he expressed understanding. Patient was discharged in stable condition.  Discharged to Home
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Basophil count, COVID-19, Cerebral ischaemia, Confusional state, Echocardiogram
Clinical narrative: Admit date: 12/24/2023  Discharge date: 1/6/2024  Reason for Admission: coffee ground emesis, SIRS, pancreatitis, and COVID infection  Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) Patient came in after several bouts of   coffee ground emesis.  He was found to meet SIRS criteria.  Source was unclear but there was findings that could be consistent with pancreatitis.  The cause of this was thought to be steroids.  Patient was empirically treated with Invanz.  He eventually underwent an EGD that showed duodenal diverticulum with friable mucosa.  He was started on BID PPI.  Review of chart showed that the patient had history of this.  Patient does have history of a previous stroke and DVT but has been kept of anticoagulation because of GIB.  During the hospitalization he was noted to  have increased confusion, work up reviewed noted multiple areas of ischemia on MRI. Patient had complete occlusion of the RIC.  Patient was seen by neurology.  Started only on ASA secondary  to the GIB.  TEE was done that showed no clots.  Tele  showed no afib.  May benefit from a event monitor.  Of note, despite antibiotics, the leukocytosis was persistent.  There was some immature cells as well as eosinophils and basophils.  This could be related to the splenectomy, but this increased WBC is pretty new to the patient.  There is some concern of CML.  BCR/ABL gene study  was sent.  Referral to hematology made, but patient was discharged on weekend so appointment wasn't scheduled.  The patient had iron deficiency anemia. He was given a dose of venofer while here and discharged on oral iron supplementation. Discharged to SNF
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Eosinophil count, Gastrointestinal haemorrhage, Gene mutation identification test, Haematemesis, Iron deficiency anaemia
Clinical narrative: Admit date: 12/24/2023  Discharge date: 1/6/2024  Reason for Admission: coffee ground emesis, SIRS, pancreatitis, and COVID infection  Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) Patient came in after several bouts of   coffee ground emesis.  He was found to meet SIRS criteria.  Source was unclear but there was findings that could be consistent with pancreatitis.  The cause of this was thought to be steroids.  Patient was empirically treated with Invanz.  He eventually underwent an EGD that showed duodenal diverticulum with friable mucosa.  He was started on BID PPI.  Review of chart showed that the patient had history of this.  Patient does have history of a previous stroke and DVT but has been kept of anticoagulation because of GIB.  During the hospitalization he was noted to  have increased confusion, work up reviewed noted multiple areas of ischemia on MRI. Patient had complete occlusion of the RIC.  Patient was seen by neurology.  Started only on ASA secondary  to the GIB.  TEE was done that showed no clots.  Tele  showed no afib.  May benefit from a event monitor.  Of note, despite antibiotics, the leukocytosis was persistent.  There was some immature cells as well as eosinophils and basophils.  This could be related to the splenectomy, but this increased WBC is pretty new to the patient.  There is some concern of CML.  BCR/ABL gene study  was sent.  Referral to hematology made, but patient was discharged on weekend so appointment wasn't scheduled.  The patient had iron deficiency anemia. He was given a dose of venofer while here and discharged on oral iron supplementation. Discharged to SNF
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Leukocytosis, Magnetic resonance imaging head abnormal, Oesophagogastroduodenoscopy abnormal, Pancreatitis, Systemic inflammatory response syndrome
Clinical narrative: Admit date: 12/24/2023  Discharge date: 1/6/2024  Reason for Admission: coffee ground emesis, SIRS, pancreatitis, and COVID infection  Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) Patient came in after several bouts of   coffee ground emesis.  He was found to meet SIRS criteria.  Source was unclear but there was findings that could be consistent with pancreatitis.  The cause of this was thought to be steroids.  Patient was empirically treated with Invanz.  He eventually underwent an EGD that showed duodenal diverticulum with friable mucosa.  He was started on BID PPI.  Review of chart showed that the patient had history of this.  Patient does have history of a previous stroke and DVT but has been kept of anticoagulation because of GIB.  During the hospitalization he was noted to  have increased confusion, work up reviewed noted multiple areas of ischemia on MRI. Patient had complete occlusion of the RIC.  Patient was seen by neurology.  Started only on ASA secondary  to the GIB.  TEE was done that showed no clots.  Tele  showed no afib.  May benefit from a event monitor.  Of note, despite antibiotics, the leukocytosis was persistent.  There was some immature cells as well as eosinophils and basophils.  This could be related to the splenectomy, but this increased WBC is pretty new to the patient.  There is some concern of CML.  BCR/ABL gene study  was sent.  Referral to hematology made, but patient was discharged on weekend so appointment wasn't scheduled.  The patient had iron deficiency anemia. He was given a dose of venofer while here and discharged on oral iron supplementation. Discharged to SNF
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Admit date: 12/24/2023  Discharge date: 1/6/2024  Reason for Admission: coffee ground emesis, SIRS, pancreatitis, and COVID infection  Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) Patient came in after several bouts of   coffee ground emesis.  He was found to meet SIRS criteria.  Source was unclear but there was findings that could be consistent with pancreatitis.  The cause of this was thought to be steroids.  Patient was empirically treated with Invanz.  He eventually underwent an EGD that showed duodenal diverticulum with friable mucosa.  He was started on BID PPI.  Review of chart showed that the patient had history of this.  Patient does have history of a previous stroke and DVT but has been kept of anticoagulation because of GIB.  During the hospitalization he was noted to  have increased confusion, work up reviewed noted multiple areas of ischemia on MRI. Patient had complete occlusion of the RIC.  Patient was seen by neurology.  Started only on ASA secondary  to the GIB.  TEE was done that showed no clots.  Tele  showed no afib.  May benefit from a event monitor.  Of note, despite antibiotics, the leukocytosis was persistent.  There was some immature cells as well as eosinophils and basophils.  This could be related to the splenectomy, but this increased WBC is pretty new to the patient.  There is some concern of CML.  BCR/ABL gene study  was sent.  Referral to hematology made, but patient was discharged on weekend so appointment wasn't scheduled.  The patient had iron deficiency anemia. He was given a dose of venofer while here and discharged on oral iron supplementation. Discharged to SNF
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient received 2nd dose of Moderna 23/24 in error. Patient is not immune compromised.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriogram coronary abnormal, Blood magnesium, Blood potassium normal, Cardiac telemetry abnormal, Cardioversion
Clinical narrative: Admission Date: 1/4/2024  Discharge Date: 1/6/2024  Discharge Diagnosis:  Ventricular tachycardia AICD discharge Coronary artery disease Ischemic cardiomyopathy Hypertension Hyperlipidemia Chronic kidney disease stage 3                             Consultations: Cardiology  Procedures: Cardiac cath / coronary angiogram on 1/5/24  Studies: Device interrogation  Hospital Course: Patient presented to the ER on 1/4/24 because he was shocked by his AICD - see HPI in the cardiology consult note for complete details. He was started on IV amiodarone and admitted to the cardiology service. To definitively evaluate for CAD causing coronary insufficiency along with his history of CAD, cardiac cath / coronary angiogram was performed on 1/5/24. Coronary angiogram demonstrated insignificant coronary artery disease with mild ischemic cardiomyopathy. There were no complications - see procedure note for complete details. On day of discharge, he was feeling well with no cardiorespiratory symptoms and was ambulating without difficulty. He was transitioned from IV amiodarone to PO amiodarone 400 mg bid x 1 week followed by amiodarone 200 mg bid thereafter for suppression of malignant ventricular arrhythmia. He received his first dose of PO amiodarone in the afternoon. He is to continue his previous dose of metoprolol succinate 50 mg daily. Due to the interaction of amiodarone with simvastatin, his simvastatin was changed to Lipitor 40 mg daily. Telemetry was reviewed and his rhythm was stable - maintaining SR with occasional isolated PVCs. His last run of NSVT was ~ 23:19 on 1/5/2024. He had no congestive or anginal symptoms. His K was 4.5 and Mg was 2.2. He was appropriately medicated with losartan for an ARB and metoprolol succinate for his beta blocker. He has an appointment with electrophysiologist on 1/18/24 at 2:30 pm. The remainder of his hospital course was unremarkable.  Per Dr, he was okay for discharge to home after transitioning from IV to PO amiodarone.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Catheterisation cardiac, Chronic kidney disease, Condition aggravated, Coronary artery disease, Coronary artery insufficiency
Clinical narrative: Admission Date: 1/4/2024  Discharge Date: 1/6/2024  Discharge Diagnosis:  Ventricular tachycardia AICD discharge Coronary artery disease Ischemic cardiomyopathy Hypertension Hyperlipidemia Chronic kidney disease stage 3                             Consultations: Cardiology  Procedures: Cardiac cath / coronary angiogram on 1/5/24  Studies: Device interrogation  Hospital Course: Patient presented to the ER on 1/4/24 because he was shocked by his AICD - see HPI in the cardiology consult note for complete details. He was started on IV amiodarone and admitted to the cardiology service. To definitively evaluate for CAD causing coronary insufficiency along with his history of CAD, cardiac cath / coronary angiogram was performed on 1/5/24. Coronary angiogram demonstrated insignificant coronary artery disease with mild ischemic cardiomyopathy. There were no complications - see procedure note for complete details. On day of discharge, he was feeling well with no cardiorespiratory symptoms and was ambulating without difficulty. He was transitioned from IV amiodarone to PO amiodarone 400 mg bid x 1 week followed by amiodarone 200 mg bid thereafter for suppression of malignant ventricular arrhythmia. He received his first dose of PO amiodarone in the afternoon. He is to continue his previous dose of metoprolol succinate 50 mg daily. Due to the interaction of amiodarone with simvastatin, his simvastatin was changed to Lipitor 40 mg daily. Telemetry was reviewed and his rhythm was stable - maintaining SR with occasional isolated PVCs. His last run of NSVT was ~ 23:19 on 1/5/2024. He had no congestive or anginal symptoms. His K was 4.5 and Mg was 2.2. He was appropriately medicated with losartan for an ARB and metoprolol succinate for his beta blocker. He has an appointment with electrophysiologist on 1/18/24 at 2:30 pm. The remainder of his hospital course was unremarkable.  Per Dr, he was okay for discharge to home after transitioning from IV to PO amiodarone.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Device function test, Hyperlipidaemia, Hypertension, Implantable defibrillator insertion, Ischaemic cardiomyopathy
Clinical narrative: Admission Date: 1/4/2024  Discharge Date: 1/6/2024  Discharge Diagnosis:  Ventricular tachycardia AICD discharge Coronary artery disease Ischemic cardiomyopathy Hypertension Hyperlipidemia Chronic kidney disease stage 3                             Consultations: Cardiology  Procedures: Cardiac cath / coronary angiogram on 1/5/24  Studies: Device interrogation  Hospital Course: Patient presented to the ER on 1/4/24 because he was shocked by his AICD - see HPI in the cardiology consult note for complete details. He was started on IV amiodarone and admitted to the cardiology service. To definitively evaluate for CAD causing coronary insufficiency along with his history of CAD, cardiac cath / coronary angiogram was performed on 1/5/24. Coronary angiogram demonstrated insignificant coronary artery disease with mild ischemic cardiomyopathy. There were no complications - see procedure note for complete details. On day of discharge, he was feeling well with no cardiorespiratory symptoms and was ambulating without difficulty. He was transitioned from IV amiodarone to PO amiodarone 400 mg bid x 1 week followed by amiodarone 200 mg bid thereafter for suppression of malignant ventricular arrhythmia. He received his first dose of PO amiodarone in the afternoon. He is to continue his previous dose of metoprolol succinate 50 mg daily. Due to the interaction of amiodarone with simvastatin, his simvastatin was changed to Lipitor 40 mg daily. Telemetry was reviewed and his rhythm was stable - maintaining SR with occasional isolated PVCs. His last run of NSVT was ~ 23:19 on 1/5/2024. He had no congestive or anginal symptoms. His K was 4.5 and Mg was 2.2. He was appropriately medicated with losartan for an ARB and metoprolol succinate for his beta blocker. He has an appointment with electrophysiologist on 1/18/24 at 2:30 pm. The remainder of his hospital course was unremarkable.  Per Dr, he was okay for discharge to home after transitioning from IV to PO amiodarone.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Sinus rhythm, Ventricular extrasystoles, Ventricular tachycardia
Clinical narrative: Admission Date: 1/4/2024  Discharge Date: 1/6/2024  Discharge Diagnosis:  Ventricular tachycardia AICD discharge Coronary artery disease Ischemic cardiomyopathy Hypertension Hyperlipidemia Chronic kidney disease stage 3                             Consultations: Cardiology  Procedures: Cardiac cath / coronary angiogram on 1/5/24  Studies: Device interrogation  Hospital Course: Patient presented to the ER on 1/4/24 because he was shocked by his AICD - see HPI in the cardiology consult note for complete details. He was started on IV amiodarone and admitted to the cardiology service. To definitively evaluate for CAD causing coronary insufficiency along with his history of CAD, cardiac cath / coronary angiogram was performed on 1/5/24. Coronary angiogram demonstrated insignificant coronary artery disease with mild ischemic cardiomyopathy. There were no complications - see procedure note for complete details. On day of discharge, he was feeling well with no cardiorespiratory symptoms and was ambulating without difficulty. He was transitioned from IV amiodarone to PO amiodarone 400 mg bid x 1 week followed by amiodarone 200 mg bid thereafter for suppression of malignant ventricular arrhythmia. He received his first dose of PO amiodarone in the afternoon. He is to continue his previous dose of metoprolol succinate 50 mg daily. Due to the interaction of amiodarone with simvastatin, his simvastatin was changed to Lipitor 40 mg daily. Telemetry was reviewed and his rhythm was stable - maintaining SR with occasional isolated PVCs. His last run of NSVT was ~ 23:19 on 1/5/2024. He had no congestive or anginal symptoms. His K was 4.5 and Mg was 2.2. He was appropriately medicated with losartan for an ARB and metoprolol succinate for his beta blocker. He has an appointment with electrophysiologist on 1/18/24 at 2:30 pm. The remainder of his hospital course was unremarkable.  Per Dr, he was okay for discharge to home after transitioning from IV to PO amiodarone.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Condition aggravated, Fatigue, Migraine, Tremor
Clinical narrative: CHills, shakes, fatigue, significant migraine
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Asthenia, Confusional state, Dyspnoea, SARS-CoV-2 test
Clinical narrative: Weakness, increased confusion, c/o shortness of breath
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Persistent, moderate, non-pulsatile, bilateral tinnitus.  Never had tinnitus before.  The tinnitus started within 24hrs of vaccine and as of this date has not resolved or diminished.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Colitis, Colitis ischaemic
Clinical narrative: Admit date: 1/4/2024  Discharge date:  01/07/2024  Admitting Physician: MD   Attending Physician at the Time of Discharge: No att. providers found  Primary Care Physician: MD  Reason for Admission:  Weakness/diarrhea  Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) patient is an 80-year-old male history of hypertension, chronic obstructive pulmonary disease, coronary artery disease/post CABG, colon cancer status post resection presented for chief complaint of weakness/diarrhea for 2 days.  Patient had tested positive for COVID at home.  On presentation patient was hypotensive received 2 L bolus in emergency department without good response was started on 2 pressor support with Levophed.  Patient was started on Rocephin/Flagyl.  Checks x-ray was largely unremarkable CT abdomen pelvis was obtained showing colitis at the region of splenic flexure, obstructing renal calculi infrarenal abdominal aorta measuring at 3.1 x 4 cm similar to 2020 study.  Patient was admitted to the intensive care unit for pressor support.  Received further IV fluids was weaned off pressor support.  Antibiotics were discontinued.  Patient was transferred to the floor.  He was able to eat drink without difficulty diarrhea resolved.  Colitis likely secondary to ischemic colitis at watershed area versus viral colitis due to COVID-19.  Patient was started back on to home blood pressure medications close monitoring of blood pressure stable at time of discharge.  He was evaluated by PT and OT with recommendations for home therapies but declined Discharged to home.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram abdomen abnormal, Diarrhoea, Hypotension, Intensive care, Nephrolithiasis
Clinical narrative: Admit date: 1/4/2024  Discharge date:  01/07/2024  Admitting Physician: MD   Attending Physician at the Time of Discharge: No att. providers found  Primary Care Physician: MD  Reason for Admission:  Weakness/diarrhea  Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) patient is an 80-year-old male history of hypertension, chronic obstructive pulmonary disease, coronary artery disease/post CABG, colon cancer status post resection presented for chief complaint of weakness/diarrhea for 2 days.  Patient had tested positive for COVID at home.  On presentation patient was hypotensive received 2 L bolus in emergency department without good response was started on 2 pressor support with Levophed.  Patient was started on Rocephin/Flagyl.  Checks x-ray was largely unremarkable CT abdomen pelvis was obtained showing colitis at the region of splenic flexure, obstructing renal calculi infrarenal abdominal aorta measuring at 3.1 x 4 cm similar to 2020 study.  Patient was admitted to the intensive care unit for pressor support.  Received further IV fluids was weaned off pressor support.  Antibiotics were discontinued.  Patient was transferred to the floor.  He was able to eat drink without difficulty diarrhea resolved.  Colitis likely secondary to ischemic colitis at watershed area versus viral colitis due to COVID-19.  Patient was started back on to home blood pressure medications close monitoring of blood pressure stable at time of discharge.  He was evaluated by PT and OT with recommendations for home therapies but declined Discharged to home.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Admit date: 1/4/2024  Discharge date:  01/07/2024  Admitting Physician: MD   Attending Physician at the Time of Discharge: No att. providers found  Primary Care Physician: MD  Reason for Admission:  Weakness/diarrhea  Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) patient is an 80-year-old male history of hypertension, chronic obstructive pulmonary disease, coronary artery disease/post CABG, colon cancer status post resection presented for chief complaint of weakness/diarrhea for 2 days.  Patient had tested positive for COVID at home.  On presentation patient was hypotensive received 2 L bolus in emergency department without good response was started on 2 pressor support with Levophed.  Patient was started on Rocephin/Flagyl.  Checks x-ray was largely unremarkable CT abdomen pelvis was obtained showing colitis at the region of splenic flexure, obstructing renal calculi infrarenal abdominal aorta measuring at 3.1 x 4 cm similar to 2020 study.  Patient was admitted to the intensive care unit for pressor support.  Received further IV fluids was weaned off pressor support.  Antibiotics were discontinued.  Patient was transferred to the floor.  He was able to eat drink without difficulty diarrhea resolved.  Colitis likely secondary to ischemic colitis at watershed area versus viral colitis due to COVID-19.  Patient was started back on to home blood pressure medications close monitoring of blood pressure stable at time of discharge.  He was evaluated by PT and OT with recommendations for home therapies but declined Discharged to home.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, COVID-19, Neurological symptom
Clinical narrative: Admit date: 1/6/2024  Discharge date: 1/7/2024   Admitting Physician: MD   Attending Physician at the Time of Discharge: No att. providers found  Primary Care Physician: MD  Reason for Admission: COVID infection  Brief Summary of Hospital Stay: Patient has underlying corticobasal degeneration )rare neurodegenerative disorder) with likely associated dementia was having increased weakness, perhaps some increased neurological symptoms.  Several attempts to obtain an MRI were unsuccessful. The patient seemed to rapidly return to baseline with just hydration without any specific COVID directed therapy.  She was not treated as she was not hypoxic on presentation.  Family requested discharge to home.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Aspiration, Blood pressure increased, COVID-19, Cough, Hypotension
Clinical narrative: Admit date: 1/2/2024  Discharge date: 1/8/2024    Reason for Admission: chemical pneumonitis, chronic recurrent aspiration   Hospital Course: 61 yo F with multiple sclerosis who is currently bed bound, and only able to speak in short sentences with very soft volulme, chronic dysphagia with aspiration, presented to emergency department on 01/02/2024 due to an episode of cough (worse than her baseline) during dinner.   Patient was initially admitted due to concern for possible aspiration pneumonia however work up was unrevealing. Given low suspicion for pneumonia patient was observed with symptomatic management and her symptoms improved significantly without needing antibiotic therapy. Patient was also incidentally noted to be COVID positive, but she denies new signs or symptoms.   With regards to chronic aspiration, patient was seen and evaluated by speech and language pathology who performed a video swallow study.   Patient is being discharged in a stable condition back to her prior living arrangement. Of note, patient's blood pressure was initially noted to be transiently low during the admission however was later noted to be elevated prior to discharge. Recommend further monitoring and outpatient follow up for management of blood pressure.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia, Pneumonitis chemical, SARS-CoV-2 test positive, Swallow study
Clinical narrative: Admit date: 1/2/2024  Discharge date: 1/8/2024    Reason for Admission: chemical pneumonitis, chronic recurrent aspiration   Hospital Course: 61 yo F with multiple sclerosis who is currently bed bound, and only able to speak in short sentences with very soft volulme, chronic dysphagia with aspiration, presented to emergency department on 01/02/2024 due to an episode of cough (worse than her baseline) during dinner.   Patient was initially admitted due to concern for possible aspiration pneumonia however work up was unrevealing. Given low suspicion for pneumonia patient was observed with symptomatic management and her symptoms improved significantly without needing antibiotic therapy. Patient was also incidentally noted to be COVID positive, but she denies new signs or symptoms.   With regards to chronic aspiration, patient was seen and evaluated by speech and language pathology who performed a video swallow study.   Patient is being discharged in a stable condition back to her prior living arrangement. Of note, patient's blood pressure was initially noted to be transiently low during the admission however was later noted to be elevated prior to discharge. Recommend further monitoring and outpatient follow up for management of blood pressure.
Age: 0.5
Sex: M
Vaccine: PNC15
Symptoms: Extra dose administered, No adverse event, Wrong product administered
Clinical narrative: Vaccine administration error. Patient received 2 dose of Vaxneuvance on 01/05/2024. While in exam room to give patient scheduled well child vaccines patient was given two doses of pneumonia 15(Vaxneuvance) as both nurses grabbed the same vaccine as his and twin sisters vaccine baskets were sitting sit by side.  Mom and dad were both notified of this and advised of any sided effects to watch out for. Dr. was also informed of double vaccination and did go in to talk to parents as well. Patient did receive 1 dose of scheduled Vaxelis as well today.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Brain natriuretic peptide increased, Diuretic therapy, Dyspnoea, Echocardiogram abnormal
Clinical narrative: Admit date: 12/29/2023  Discharge date: 1/8/2024  Admitting Physician: MD   Attending Physician at the Time of Discharge: MD  Primary Care Physician: MD  Brief Summary of Hospital Stay:Patient is 82 years old male with past medical history of AFib, coronary artery disease with stent placement and pacemaker presented with shortness of breath and generalized weakness.  In the emergency department he was found to have elevated troponin level in 80s.  EKG did not show sign of ischemic changes, but prolonged QT interval.  Echo showed reduced EF 45 to 55%.  BNP in the 3000.  Cardiology was consulted.  Patient was supposed to get a stress the next morning.  However while getting ready for the test, patient had a syncope episode.  He was admitted for further evaluation and management. ICD interrogation didn't show significant arrhythmia. He was diuresed with IV lasix with good urine output.  Patient was positive for orthostatic hypotension. Midodrine and Florinef were started. Hydrocortisone then replaced Florinef due to concern for secondary adrenal insufficiency per Endocrine recommendation. Patient was doing better this morning and discharged home to follow up with PCP, Cardiology and Endocrine. Recommend torsemide daily PRN for weight gain and thigh high compression stocking.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Ejection fraction decreased, Electrocardiogram QT prolonged, Orthostatic hypotension, Syncope, Troponin increased
Clinical narrative: Admit date: 12/29/2023  Discharge date: 1/8/2024  Admitting Physician: MD   Attending Physician at the Time of Discharge: MD  Primary Care Physician: MD  Brief Summary of Hospital Stay:Patient is 82 years old male with past medical history of AFib, coronary artery disease with stent placement and pacemaker presented with shortness of breath and generalized weakness.  In the emergency department he was found to have elevated troponin level in 80s.  EKG did not show sign of ischemic changes, but prolonged QT interval.  Echo showed reduced EF 45 to 55%.  BNP in the 3000.  Cardiology was consulted.  Patient was supposed to get a stress the next morning.  However while getting ready for the test, patient had a syncope episode.  He was admitted for further evaluation and management. ICD interrogation didn't show significant arrhythmia. He was diuresed with IV lasix with good urine output.  Patient was positive for orthostatic hypotension. Midodrine and Florinef were started. Hydrocortisone then replaced Florinef due to concern for secondary adrenal insufficiency per Endocrine recommendation. Patient was doing better this morning and discharged home to follow up with PCP, Cardiology and Endocrine. Recommend torsemide daily PRN for weight gain and thigh high compression stocking.
Age: 84.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Immediate post-injection reaction, Injection site pain, Limb discomfort, Mobility decreased
Clinical narrative: He got his vaccine, it started to hurt immediately, but not excruciating, uncomfortable after she gave it to him.  By the end of the day he was really hurting with it.  His arm started to swell and then the next morning he could hardly get out of the bed to go to the restroom.  His arm felt like it was twice the size it should of been, and his muscles and joints hurt to where he felt like somebody had beaten him up.  He did not have any desire to get up or doing anything or making himself something to eat.  On Sunday he was able to get up and get him some breakfast, and then he was able to move around.  He did not feel like going anywhere or doing anything, but not as near as he was the day before.  His arm was still sore and felt quite swollen.  Monday he was a little bit better, yesterday he actually got out, but was still sore and tender.  Today his arm is still hurting, but much better than it was before.  He tried some medicine that did not help his symptoms.  It's much better today, and has an APT to get a haircut this afternoon.   He feels he is back to being almost normal.
Age: 84.0
Sex: M
Vaccine: VARZOS
Symptoms: Myalgia, Pain in extremity, Peripheral swelling, Tenderness
Clinical narrative: He got his vaccine, it started to hurt immediately, but not excruciating, uncomfortable after she gave it to him.  By the end of the day he was really hurting with it.  His arm started to swell and then the next morning he could hardly get out of the bed to go to the restroom.  His arm felt like it was twice the size it should of been, and his muscles and joints hurt to where he felt like somebody had beaten him up.  He did not have any desire to get up or doing anything or making himself something to eat.  On Sunday he was able to get up and get him some breakfast, and then he was able to move around.  He did not feel like going anywhere or doing anything, but not as near as he was the day before.  His arm was still sore and felt quite swollen.  Monday he was a little bit better, yesterday he actually got out, but was still sore and tender.  Today his arm is still hurting, but much better than it was before.  He tried some medicine that did not help his symptoms.  It's much better today, and has an APT to get a haircut this afternoon.   He feels he is back to being almost normal.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Hives on my arm,  rash on my leg
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine given post expiration date
Age: 66.0
Sex: M
Vaccine: RSV
Symptoms: Arrhythmia, Dyspnoea, Palpitations
Clinical narrative: Patient said hours after the vaccine, his heart started racing and he had difficulty breathing. He had a similar reaction to a covid vaccine (pfizer) so he tried to wait it out. He finally went to a doctor and he now has an arrhythmia which he had to start medication to manage. He also reported from time to time he continues to have shortness of breathe.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine give post expiration date
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine give post expiration date
Age: 72.0
Sex: M
Vaccine: RSV
Symptoms: Aphasia, Cerebrovascular accident, Swollen tongue
Clinical narrative: Patient woke up 4 days after vaccine with his tongue swollen and unable to talk. He went to the hospital and was told he had a stroke.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine given post expiration date
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None stated.
Age: 10.0
Sex: M
Vaccine: FLU4, HPV9
Symptoms: Immediate post-injection reaction, Injection site pain, Pain in extremity
Clinical narrative: Significant pain at time of administration.   Continued pain for 13 days.  Vaccine given 12/28/23.  Sought care for continued right arm pain on 1/10/24.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: N./A
Age: 5.0
Sex: F
Vaccine: DTAPHEPBIP, HEPA, HIBV, PNC15
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event occurred, and patient has been seen since event occurred.
Age: 0.5
Sex: M
Vaccine: FLU4
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Administration error- A Fluarix vaccine was given on 10/7/23, but the patient had just received his first dose of Fluarix on 10/3/23. The dose on 10/7/23 was given too soon. (His 1 month follow up appointment was moved to 10/7/23 by mistake.) There were no side effects and the patient has been fine since the vaccine error.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None stated.
Age: 55.0
Sex: F
Vaccine: PNC20
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Pt is doing okay, pt was verbally informed if she would like the pneumonia vaccination.  Pt had pneumonia previously two months ago.  Pt received information sheet for self report when she had come in to report to clinic. She had wanted the OV summary to reflect her vaccination at the time of visit. She notes that it did not state that in her notes. Relayed that due to patient care and at the end of the day visit they may have not had time to place it in the system until after but the record of vaccination is in the system. Pt notes that currently she is doing fine and just has a mark left where the injection was given, no longer experiencing pain or other adverse affects like swelling and redness. No further questions or concerns we will send her an updated OV summary with her injection.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None stated.
Age: 68.0
Sex: M
Vaccine: FLU4
Symptoms: HIV test false positive, HIV test negative, Lower urinary tract symptoms, Paraesthesia oral, Pharyngeal swelling
Clinical narrative: After patient have high dose flu shot he complained paresthesias of the mouth and perceived swelling of the throat. Vitals were monitored serially every 5-10 mins x30 mins. He was then rechecked by physician and sent home. Then came in and saw another provider 12/14/23 with symptoms of UTI, was treated but was no better and worse by next appt 12/21. STD testing completed and Pt test positive for HIV. Referral sent to ID. Another round of HIV testing showed patient was NOT positive for HIV.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None stated.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None stated.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None stated.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: None stated.
Age: 0.08
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Rash
Clinical narrative: + RASH over his body - mother has pictures on her phone and shared with provider as I did not see the pt with the rash
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Atrial septal defect, Blood cholesterol normal, Blood potassium decreased, Computerised tomogram head normal, Echocardiogram
Clinical narrative: Received COVID vaccine on 11/21/2023, on 11/30/2023 at 0600 am I also received the Influenza vaccine.  At approximately 10:40 am on 11/30/2023, I developed weakness and heaviness in my left leg and arm, diaphoretic and pale ( per co workers). Brought to the Emergency room and ultimately diagnosed with a small lacunar stroke.  I believe this to be related to the COVID vaccine,.
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Echocardiogram abnormal, Glycosylated haemoglobin normal, Hemiparesis, Hyperhidrosis, Laboratory test normal
Clinical narrative: Received COVID vaccine on 11/21/2023, on 11/30/2023 at 0600 am I also received the Influenza vaccine.  At approximately 10:40 am on 11/30/2023, I developed weakness and heaviness in my left leg and arm, diaphoretic and pale ( per co workers). Brought to the Emergency room and ultimately diagnosed with a small lacunar stroke.  I believe this to be related to the COVID vaccine,.
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Lacunar stroke, Limb discomfort, Magnetic resonance imaging head abnormal, Muscular weakness, Pallor
Clinical narrative: Received COVID vaccine on 11/21/2023, on 11/30/2023 at 0600 am I also received the Influenza vaccine.  At approximately 10:40 am on 11/30/2023, I developed weakness and heaviness in my left leg and arm, diaphoretic and pale ( per co workers). Brought to the Emergency room and ultimately diagnosed with a small lacunar stroke.  I believe this to be related to the COVID vaccine,.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Lymphadenopathy
Clinical narrative: Patient reports having swollen neck lymph node on her left side next day the size of a grape.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Spikevax. Patient reported vomiting for 12 hours with a major headache starting the day she received vaccines and is still feeling crummy 5 days later when she called.
Age: 31.0
Sex: F
Vaccine: TDAP
Symptoms: Delivery, Exposure during pregnancy
Clinical narrative: I gave birth to a baby boy, it was a spontaneous, vaginal, unmedicated, uncomplicated delivery.  My son was 8 lbs 14 oz and I was full term, 40 weeks and 3 days. My son has global developmental delays and a genetic disorder called Kleefstra Syndrome, we received this diagnosis in December 2023 after over a year of seeing specialists and doing testing.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pt was given covid vaccine on 12/27/23, but the vaccine expired on 12/22/23.
Age: 0.33
Sex: M
Vaccine: RSV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: NO ADVERSE EVENT HAPPENED>Patient was given wrong vaccine.  Provider called spoke with mom.  Baby was doing well not having any problems.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalized with COVID
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Malaise, Pyrexia, Somnolence, Syncope
Clinical narrative: Fever malaise sleepiness. Followed by lightheadedness and nearly fainting twice.
Age: 66.0
Sex: F
Vaccine: FLU4
Symptoms: Angioedema, Chills, Extra dose administered, Peripheral swelling, Pyrexia
Clinical narrative: Patient reported swelling of arm of administration on 1/9/2024, no SOB, angioedema, fever or chills. Was booked with a next day appointment on 1/10/2023 and also sent a prescription for Benadryl. Was followed up with later in the day on 1/9/2024 with no progression or worsening of swelling, and advised to ice/heat arm, and was counseled on red flag symptoms for Emergency department. Patient did well overnight and will have appointment today, 1/10/2024 with a clinic provider. Patient did received a flu shot earlier this season on 10/5/2023 at 12:20 pm, manufacturer Sanofi Pasteur and Lot #UT8111BA without issue.  This flu shot was the second of this season.
Age: 66.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Injection site pain, Mobility decreased, Scar
Clinical narrative: Patient reported local site pain and limited range of motion after administration of two vaccines in the same arm >3 weeks after administration. Patient completed a 5 day course of prednisone 40mg daily and is continuing to report local site soreness, pain, and limited range of motion. Patient does have scar tissue near injection site from an old skin graft. The patient reported that he has received vaccinations in that arm previously without issue. When discussing with patient, reported pain was near/associated with the scar tissue covered area.
Age: 88.0
Sex: M
Vaccine: RSV
Symptoms: Cardiac disorder, Electrocardiogram
Clinical narrative: atrial